Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael E. Perlman is active.

Publication


Featured researches published by Michael E. Perlman.


Bioorganic & Medicinal Chemistry Letters | 2001

Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers.

Seetharamaiyer Padmanabhan; Ruth C. Lavin; Paresh Thakker; Jinqing Guo; Lu Zhang; Deke Moore; Michael E. Perlman; Cassandra Kirk; Deborah Daly; Kathy J Burke-Howie; Teresa Wolcott; Suchitra Chari; David J. Berlove; James B. Fischer; William F. Holt; Graham John Durant; Robert N. McBurney

Solution-phase synthesis of various acylguanidine derivatives and the evaluation of a small library of compounds as potential sodium channel blockers are described.


International Journal of Radiation Oncology Biology Physics | 1979

Chemical mechanism of the radiation potentiating effects of 2,2-Dimethylaziridine-type antitumor agents☆

Thomas J. Bardos; Joseph A. Dunn; Michael E. Perlman

Abstract Three 2,2-dimethyl phosphoraziridines, bis(2,2-dimethylaziridinyl)phosphinyl urethane (AB-132, NSC 51325), ethyl bis(2,2-dimethylaziridinyi)phosphinate (AB-163 NSC 108878) and bis(2,2-dimethylaziridinyl)-N-hydroxyurethane (AB-182, NSC 200724) which have shown synergistic antitumor effects in conjunction with X-irradiation, are characterized by their rapid hydrolysis via S N 1-mechanism and via the formation of transient 5-membered cyclic intermediates exhibiting phosphorylating activities. It was shown that the formation of the latter correlates with the observed maxima in the cholinesterase inhibitory effects of these compounds. It is proposed that the same intermediate hydrolysis products may block the repair of X-irradiation induced breaks in the DNA strands by phosphorylating their free YOH end groups. Additional mechanisms of the radiation potentiating effects of these compounds (not shown by their C-unsubstituted analogs), involving free radical-ion formation, are currently under investigation.


Journal of Medicinal Chemistry | 1985

Nucleosides. 133. Synthesis of 5-alkenyl-1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)cytosines and related pyrimidine nucleosides as potential antiviral agents

Michael E. Perlman; Kyoichi A. Watanabe; Raymond F. Schinazi; Jack J. Fox


Nuclear Medicine and Biology | 2000

Synthesis and binding characteristics of N-(1-naphthyl)-N′-(3-[125I]-iodophenyl)-N′-methylguanidine ([125I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activation

Jonathan Owens; Andrew A Tebbutt; Ailsa L McGregor; K Kodama; Sharad Magar; Michael E. Perlman; David J. Robins; Graham John Durant; James McCulloch


Journal of Medicinal Chemistry | 1998

Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N, N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channels

Michel Maillard; Michael E. Perlman; Oved Amitay; Deborah Baxter; David J. Berlove; Sonia Connaughton; James B. Fischer; Jun Qing Guo; Lain-Yen Hu; Robert N. McBurney; Peter I. Nagy; Katragadda Subbarao; Elizabeth Yost; Lu Zhang; Graham John Durant


Bioorganic & Medicinal Chemistry Letters | 2001

Identification and characterization of a potential ischemia-selective N-methyl-D-aspartate (NMDA) receptor ion-channel blocker, CNS 5788.

Seetharamaiyer Padmanabhan; Michael E. Perlman; Lu Zhang; Deke Moore; Dan Zhou; James B. Fischer; Graham John Durant; Robert N. McBurney


Journal of Medicinal Chemistry | 1991

Synthesis of potential dual-acting radiation sensitizer antineoplastic agents : 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties

Michael E. Perlman; Joseph A. Dunn; Thomas A. Piscitelli; Julie Earle; William C. Rose; Galen L. Wampler; Joan E. MacDiarmid; Thomas J. Bardos


Journal of Organic Chemistry | 1988

Synthesis, molecular symmetry, and chemical reactivity of C-aryl-substituted phosphoraziridines

Michael E. Perlman; Thomas J. Bardos


Journal of Medicinal Chemistry | 1985

Synthesis and properties of bis(2,2-dimethylaziridinyl)phosphinic amides: a series of new antineoplastic agents.

Joan E. MacDiarmid; William C. Rose; William C. Biddle; Michael E. Perlman; Robert G. Breiner; Thomas J. Bardos


Archive | 1998

Pharmaceutically active compound and methods of use

Graham John Durant; Michael E. Perlman; James B. Fischer; Seetharamaiyer Padmanabhan

Collaboration


Dive into the Michael E. Perlman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joan E. MacDiarmid

State University of New York System

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kyoichi A. Watanabe

Memorial Sloan Kettering Cancer Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge